The news. The narrative. The timeline.
Bureau: Chicago
Six days after Cochrane's pooled 20,342-patient finding, the FDA, Biogen, CMS, and Eli Lilly have said nothing, and the reimbursement pipeline for a $26,500-per-year drug continues.
Qatari helium deliveries for UK hospitals will not arrive per BMJ April 13, and nine days on the NIH has still said nothing about triage in the US.
The 80-and-older cohort finished the coldest Boston in a decade — a Parkinson's patient at 80, a stage-three prostate-cancer patient at 80, and a 60-year-old returned astronaut all in the field.
Day five of Kennedy's "better than Mexico" measles claim, neither retracted nor amplified, against a CDC count of 1,748 cases and an AP fact-check ruling it false.
CDC's flagship surveillance report ran 44 cases of invasive Hib among homeless adults on April 16 and has posted nothing on measles past 700 in Texas or bovine H5N1 since.
A missense variant in GLP1R carried by roughly 40% of European-ancestry patients adds 1.7 pounds of weight loss — and hands payers a stratification lever they did not have in March.
A seven-year SHARE study of 10,217 older Europeans finds loneliness lowers baseline memory but does not speed its decline — tensioning the paper's own demographic-winter frame.
Trump Accounts pay $1,000 for babies born 2025-2028 and a separate $5,000 baby-bonus proposal still sits on the desk as Day 2 of the live thread adds no new dollar figure.